SCHEMBL6169375

SCHEMBL6169375

O=C1C(c2ccc(Cl)cc2)NC(=S)N1c1ccc(Cc2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C19 P33261 1/20 0.50
ALDH1A1 P00352 2/20 0.48
MAPT P10636 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
ATM Q13315 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SMO Q99835 2/20 0.44
CNR1 P21554 1/20 0.41
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
ADCY2 Q08462 1/20 0.40
HTT P42858 1/20 0.40
NR3C1 P04150 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
AR P10275 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167967 0.84 ALDH1A1 (0.52) GAACYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL6167361 0.79 GAA (0.58) GAACYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL13879419 0.75 AR (0.62) GAACYP3A4CYP2C19ALDH1A1MAPT
SCHEMBL9638554 0.73 GAA (0.84) GAACYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL5955265 0.73 MEN1 (0.54) GAACYP3A4ALDH1A1SMOLMNA
SCHEMBL5954448 0.72 SMO (0.56) GAAALDH1A1MAPTRAB9ASMO
SCHEMBL6169513 0.72 L3MBTL1 (0.48) GAACYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL6169699 0.72 GAA (0.49) GAACYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL6626137 0.72 MAPT (0.50) GAACYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL9638535 0.71 GAA (0.84) GAACYP1A2CYP3A4CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546111-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2005-06-29 EP disclosed
WO-2004031160-A2 2-THIOHYDANTOINE DERIVATIVE COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DIABETES LABORATOIRES FOURNIER S.A. (FR) 2004-04-15 WO disclosed